Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$0.53 - $0.93 $17,469 - $30,653
32,961 Added 99.48%
66,094 $38,000
Q4 2023

Feb 02, 2024

BUY
$0.63 - $1.14 $20,873 - $37,771
33,133 New
33,133 $27,000
Q4 2022

Feb 02, 2023

BUY
$2.02 - $3.25 $19,949 - $32,097
9,876 Added 1646.0%
10,476 $25,000
Q3 2022

Nov 04, 2022

SELL
$1.96 - $3.14 $174,363 - $279,337
-88,961 Reduced 99.33%
600 $1,000
Q2 2022

Aug 03, 2022

BUY
$1.3 - $2.64 $36,507 - $74,139
28,083 Added 45.68%
89,561 $173,000
Q1 2022

May 02, 2022

SELL
$2.35 - $3.47 $7,484 - $11,051
-3,185 Reduced 4.93%
61,478 $151,000
Q4 2021

Feb 23, 2022

BUY
$2.92 - $5.74 $187,063 - $367,721
64,063 Added 10677.17%
64,663 $208,000
Q2 2021

Aug 12, 2021

SELL
$2.56 - $5.49 $159,357 - $341,747
-62,249 Reduced 99.05%
600 $3,000
Q1 2021

Apr 26, 2021

BUY
$2.69 - $5.25 $118,206 - $230,700
43,943 Added 232.43%
62,849 $170,000
Q4 2020

Feb 02, 2021

SELL
$3.17 - $4.49 $186,250 - $263,805
-58,754 Reduced 75.66%
18,906 $60,000
Q3 2020

Oct 14, 2020

BUY
$2.98 - $5.2 $197,314 - $344,307
66,213 Added 578.43%
77,660 $310,000
Q2 2020

Jul 13, 2020

SELL
$2.29 - $4.24 $16,895 - $31,282
-7,378 Reduced 39.19%
11,447 $44,000
Q1 2020

Apr 29, 2020

SELL
$1.92 - $4.39 $31,950 - $73,053
-16,641 Reduced 46.92%
18,825 $46,000
Q4 2019

Feb 05, 2020

BUY
$2.41 - $4.4 $85,473 - $156,050
35,466 New
35,466 $144,000
Q3 2019

Oct 15, 2019

SELL
$2.17 - $3.14 $134,372 - $194,438
-61,923 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$2.53 - $3.04 $46,853 - $56,297
-18,519 Reduced 23.02%
61,923 $185,000
Q1 2019

Apr 18, 2019

BUY
$2.51 - $3.73 $173,375 - $257,646
69,074 Added 607.62%
80,442 $0
Q4 2018

Jan 16, 2019

SELL
$1.59 - $2.66 $73,410 - $122,812
-46,170 Reduced 80.24%
11,368 $27,000
Q3 2018

Oct 23, 2018

BUY
$1.59 - $2.42 $82,799 - $126,021
52,075 Added 953.23%
57,538 $123,000
Q2 2018

Jul 30, 2018

SELL
$2.26 - $4.65 $456 - $939
-202 Reduced 3.57%
5,463 $12,000
Q1 2018

Apr 26, 2018

SELL
$3.51 - $6.04 $1,453 - $2,500
-414 Reduced 6.81%
5,665 $26,000
Q4 2017

Jan 10, 2018

SELL
$3.26 - $4.78 $37,014 - $54,272
-11,354 Reduced 65.13%
6,079 $19,000
Q3 2017

Oct 25, 2017

BUY
$3.48 - $4.44 $60,666 - $77,402
17,433
17,433 $76,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.